Expression of Erk5 in early stage breast cancer and association with disease free survival identifies this kinase as a potential therapeutic target.

PLoS One · 2009 · PMC2678256 · PMID 19440538

Europe PMC DOI

hedged sentence

0.0740

closest p · 1.5× alpha

0.0740

boldest claim

The sentences

showed a trendp = 0.074so close (0.05 < p ≤ 0.1)

Immunohistochemical analyses of HER2 and Erk5 expression in the patient series showed a trend towards a positive correlation between high expression level of Erk5 and HER2 positivity ( p = 0.074).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.